The Latest
-
US, China agree to reduce tariff rates for 90 days
By Wednesday, the two countries will charge 10% baseline duties during the period and remove certain retaliatory levies that pushed rates over 100%.
-
Earnings & Tariffs
Solventum’s projected $100M tariff hit prevents earnings increase
CEO Bryan Hanson said tariffs have given “a higher sense of urgency” to the company’s existing efforts to regionalize its supply chains.
-
New Insulet CEO Ashley McEvoy sets priorities
The diabetes tech company raised its expectations for revenue and gross margins, despite the impact of tariffs.
-
SEC ends probe of Illumina’s Grail acquisition
The DNA sequencing company also cut its 2025 earnings outlook to reflect the impact of tariffs on its business.
-
Q&A
ADA’s Osagie Ebekozien on diabetes tech for Type 2, new CGM standards
Ebekozien, chief quality officer of the American Diabetes Association, said the nonprofit is seeing a shift with more devices authorized for Type 2 diabetes.
-
FDA, aiming to speed scientific reviews, names chief AI officer
Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA scientists spend less time on repetitive tasks.